Skip to main content
SpringerLink
Log in

Relationship Between Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Since aplastic anemia—paroxysmal nocturnal hemoglobinuria syndrome was reported in 1967, the overlap of idiopathic aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH) has been well known.The link between the 2 diseases became even more evident when immunosuppressive therapy improved survival of patients with severe AA. More than 10% of patients with AA develop clinically evident PNH. Moreover, flow cytometric analysis demonstrates that the majority of patients with AA have a subclinical percentage of granulocytes with PNH phenotype. Some of them have clearly recognizable PNH clones. Granulocytes with a PNH phenotype are also often found in normal individuals, though at much smaller percentages of cells. This finding suggests that a PNH clone is expanded in AA, consistent with a hypothesis that blood cells from patients with PNH are more resistant to an autoimmune environment. Survival of PNH clones in pathologic bone marrow may account for limited expansion of PNH clones; however, additional genetic change(s) that confers cells with growth phenotype may be required for the full development of PNH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lewis SM, Dacie JV. The aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome.Br J Haematol. 1967;13:236–251.

    Article  CAS  PubMed  Google Scholar 

  2. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia.Br J Haematol. 1988;69:413–418.

    Article  CAS  PubMed  Google Scholar 

  3. de Planque MM, Bacigalupo A, Wursch A, et al. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT).Br J Haematol. 1989;73:121–126.

    Article  PubMed  Google Scholar 

  4. Najean Y, Haguenauer O. Long-term (5 to 20 years) evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias.Blood. 1990;76:2222–2228.

    PubMed  CAS  Google Scholar 

  5. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia.N Engl J Med. 1997;336:1365–1372.

    Article  CAS  PubMed  Google Scholar 

  6. Young NS. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia.Semin Hematol. 2000;37:3–14.

    Article  CAS  PubMed  Google Scholar 

  7. Rosse WF. New insights into paroxysmal nocturnal hemoglobinuria.Curr Opin Hematol. 2001;8:61–67.

    Article  CAS  PubMed  Google Scholar 

  8. Luzzatto L, Bessler M, Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise?Cell. 1997;88:1–4.

    Article  CAS  PubMed  Google Scholar 

  9. Watanabe R, Murakami Y, Marmor MD, et al. Initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG-P and is regulated by DPM2.EMBO J. 2000;19:4402–4411.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kostova Z, Rancour DM, Menon AK, Orlean P. Photoaffinity labelling with P3-(4-azidoanilido)uridine 5′-triphosphate identifies Gpi3p as the UDP-GlcNAc-binding subunit of the enzyme that catalyses formation of GlcNAc-phosphatidylinositol, the first glycolipid intermediate in glycosylphosphatidylinositol synthesis.Biochem J. 2000;350:815–822.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of thePIG-A gene in paroxysmal nocturnal hemoglobinuria.Cell. 1993;73:703–711.

    Article  CAS  PubMed  Google Scholar 

  12. Nishimura J, Hirota T, Kanakura Y, et al. Long-term support of hematopoiesis by a single cell clone in patients with paroxysmal nocturnal hemoglobinuria.Blood. In press.

  13. Terstappen L, Nguyen M, Huang S, Lazarus HM, Medof ME. Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria.Br J Haematol. 1993;84:504–514.

    Article  CAS  PubMed  Google Scholar 

  14. Yamada N, Miyata T, Maeda K, Kitani T, Takeda J, Kinoshita T. Somatic mutations of thePIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria.Blood. 1995;85:885–892.

    PubMed  CAS  Google Scholar 

  15. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals.Proc Natl Acad Sci U S A. 1999;96:5209–5214.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kawagoe K, Kitamura D, Okabe M, et al. GPI-anchor deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.Blood. 1996;87:3600–3606.

    PubMed  CAS  Google Scholar 

  17. Rosti V, Tremmi G, Soares V, Pandolfi PP, Luzzatto L, Bessler M. Murine embryonic stem cells withoutpig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.J Clin Invest. 1997;100:1028–1036.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Murakami Y, Kinoshita T, Maeda Y, Nakano T, Kosaka H, Takeda J. Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by model mice of paroxysmal nocturnal hemoglobinuria.Blood. 1999;94:2963–2970.

    PubMed  CAS  Google Scholar 

  19. Tremml G, Dominguez C, Rosti V, et al. Increased sensitivity to complement and a decreased red cell life span in mice mosaic for a non-functionalPiga gene.Blood. 1999;94:2945–2954.

    CAS  PubMed  Google Scholar 

  20. Keller P, Tremml G, Rosti V, Bessler M. X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation.Proc Natl Acad Sci U S A. 1999;96:7479–7483.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Keller P, Payne JL, Tremml G, et al. FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hamatopoietic stem cells in the bone marrow.J Exp Med. 2001;194:581–589.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Schubert J, Vogt HG, Zielinska Skowronek M, et al. Development of the glycosylphosphatidylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia.Blood. 1994;83:2323–2328.

    PubMed  CAS  Google Scholar 

  23. Schrezenmeier H, Hertenstein B, Wagner B, Raghavachar A, Heimpel HA. Pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins.Exp Hematol. 1995;23:81–87.

    PubMed  CAS  Google Scholar 

  24. Griscelli-Bennaceur A, Gluckman E, Scrobohaci ML, et al. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link.Blood. 1995;85:1354–1363.

    PubMed  CAS  Google Scholar 

  25. De Lord C, Tooze JA, Saso R, Marsh JCW, Gordon-Smith EC. Deficiency of glycosylphosphatidyl inositol-anchored proteins in patients with aplastic anaemia does not affect response to immuno-suppressive therapy.Br J Haematol. 1998;101:90–93.

    Article  PubMed  Google Scholar 

  26. Azenishi Y, Ueda E, Machii T, et al. CD59-deficient blood cells and PIG-A gene abnormalities in Japanese patients with aplastic anaemia.Br J Haematol. 1999;104:523–529.

    Article  CAS  PubMed  Google Scholar 

  27. Dunn DE, Tanawattanacharoen P, Boccuni P, et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.Ann Intern Med. 1999;131:401–408.

    Article  CAS  PubMed  Google Scholar 

  28. Wang H, Chuhjo T, Yamazaki H, et al. Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: the high prevalence at diagnosis.Eur J Haematol. 2001;66:200–205.

    Article  CAS  PubMed  Google Scholar 

  29. Mukhina GL, Buckley JT, Barber JP, Jones RJ, Brodsky RA. Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia.Br J Haematol. 2001;115:476–482.

    Article  CAS  PubMed  Google Scholar 

  30. Nagarajan S, Brodsky RA, Young NS, Medof ME. Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia.Blood. 1995;86:4656–4661.

    PubMed  CAS  Google Scholar 

  31. Rotoli B, Luzzatto L. Paroxysmal nocturnal haemoglobinuria.Baillieres Clin Haematol. 1989;2:113–138.

    Article  CAS  PubMed  Google Scholar 

  32. Young NS. The problem of clonality in aplastic anemia: Dr Dameshek’s riddle, restated.Blood. 1992;79:1385–1392.

    PubMed  CAS  Google Scholar 

  33. Young NS, Maciejewski JP. Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this littlePIG-A goes “Why? Why? Why?”J Clin Invest. 2000;106:637–641.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Karadimitris A, Luzzatto L. The cellular pathogenesis of paroxysmal nocturnal haemoglobinuria.Leukemia. 2001;15:1148–1152.

    Article  CAS  PubMed  Google Scholar 

  35. Hollander N, Selvaraj P, Springer TA. Biosynthesis and function of LFA-3 in human mutant cells deficient in phosphatidylinositol-anchored proteins.J Immunol. 1988;141:4283–4290.

    PubMed  CAS  Google Scholar 

  36. Karadimitris A, Notaro R, Koehne G, Roberts IA, Luzzatto L. PNH cells are as sensitive to T-cell-mediated lysis as their normal counterparts: implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria.Br J Haematol. 2000;111:1158–1163.

    Article  CAS  PubMed  Google Scholar 

  37. Murakami Y, Kosaka H, Takeda J, Kinoshita T. Two possible mechanisms for escape of GPI- cells from the immunological attack. Paper presented at: International Symposium on PNH and Related Diseases; August 28–29,2001;Tokyo, Japan.

  38. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells.Nat Immunol. 2001;2:255–260.

    Article  CAS  PubMed  Google Scholar 

  39. Cosman D, Mullberg J, Sutherland CL, et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.Immunity. 2001;14:123–133.

    Article  CAS  PubMed  Google Scholar 

  40. Girardi M, Oppenheim DE, Steele CR, et al. Regulation of cutaneous malignancy by γδ T cells.Science. 2001;294:605–609.

    Article  CAS  PubMed  Google Scholar 

  41. Rammensee H-G, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing.Immunogenetics. 1995;41:178–228.

    Article  CAS  PubMed  Google Scholar 

  42. Joyce S, Woods AS, Yewdell JW, et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.Science. 1998;279:1541–1544.

    Article  CAS  PubMed  Google Scholar 

  43. Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-medi-ated activation of Vα14 NKT cells by glycosylceramides.Science. 1997;278:1626–1629.

    Article  CAS  PubMed  Google Scholar 

  44. Cerwenka A, Bakker ABH, McClanahan T, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.Immunity. 2000;12:721–727.

    Article  CAS  PubMed  Google Scholar 

  45. Brodsky RA, Vala MS, Barber JP, Medof ME, Jones RJ. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria.Proc Natl Acad Sci U S A. 1997;94:8756–8760.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Horikawa K, Nakakuma H, Kawaguchi T, et al. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome.Blood. 1997;90:2716–2722.

    PubMed  CAS  Google Scholar 

  47. Ware RE, Nishimura J, Moody MA, Smith C, Rosse WF, Howard TA. The PIG-A mutation and absence of glycosylphosphatidyli-nositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria.Blood. 1998;92:2541–2550.

    PubMed  CAS  Google Scholar 

  48. Bastisch I, Tiede A, Deckert M, Ziolek A, Schmidt RE, Schubert J. Glycosylphosphatidylinositol (GPI)-deficient Jurkat T cells as a model to study functions of GPI-anchored proteins.Clin Exp Immunol. 2000;122:49–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Chen R, Nagarajan S, Prince GM, et al. Impaired growth and elevated Fas receptor expression inPIGA+ stem cells in primary paroxysmal nocturnal hemoglobinuria.J Clin Invest. 2000;106:689–696.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Schrezenmeier H, HildebrandA, Rojewski M, Hacker H, Heimpel H, Raghavachar A. Paroxysmal nocturnal haemoglobinuria: a replacement of haematopoietic tissue?Acta Haematol. 2000;103:41–48.

    Article  CAS  PubMed  Google Scholar 

  51. Lyakisheva A, Felda O, Ganser A, Schmidt RE, Schubert J. Paroxysmal nocturnal hemoglobinuria: differential gene expression of EGR-1 and TAXREB107.Exp Hematol. 2002;30:18–25.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka

    Taroh Kinoshita

  2. Department of Molecular Genetics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

    Norimitsu Inoue

Authors
  1. Taroh Kinoshita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norimitsu Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Kinoshita, T., Inoue, N. Relationship Between Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. Int J Hematol 75, 117–122 (2002). https://doi.org/10.1007/BF02982015

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02982015

Key words

Search

Navigation